Aeropharm Technology, Inc.

Other

Iep Pharmaceutical Devices Inc.

Kos Pharmaceuticals, Incorporated

Wilfred-ramix, Inc.

Kos Life Science, Inc.

Akwete Lex Adjei

Anthony J Cutie

Yaping Zhu

Frederick A Sexton

Simon G Stefanos

John Z Sun

Perry Arthur Genova

Debrah Boateng

Michael Nsiah Doudu

Kofi Ampim

Frederick Asiedu

Charles Antwi Boateng

William Owusu

Manny Ennin

William Asiedu

Kwasi Appiah-Kubi

Seth Opoku Ware

Lukeysha Kline

Richard Joel Melker

Johannes Hugo Van Oostrom

Anthony A Mancuso

Ilona Maria Schmalfuss

Fred Sexton

Yazping Zhu

Federick Sexton

An Aids and associated conditions related to Aids treating compositions is disclosed. The compositions comprise: a medicament selected from an extract of at least one of the following plant families: Apocynaceae (); Annonaceae (); Dichapetalaceae (); Annoceae (); Cynocynaceae (); Asclepiadaceae (); Combretaceae (); Apocynaceae (); Amaranthaceae (); Aroceae (); Cyperaceae (); Anacardiaceae (); Bignodaceae (); Bombacaceae (); Anarcardiaceae (); Bombacaceae (): Anarcardiaceae (); Caricaceae (); a glyceryl ester of any of the foregoing extracts; a saponin of any of the foregoing extracts; an alkaloid of any of the foregoing extracts; a protein of any of the foregoing extracts; a fat of any of the foregoing extracts; a sugar of any of the foregoing extracts; and any mixture of any of the foregoing.

Composition for treating aids and associated conditions

An Aids and associated conditions related to Aids treating compositions is disclosed. The compositions comprise: a medicament selected from an extract of at least one of the following plant families: Apocynaceae (); Annonaceae (); Dichapetalaceae (); Annoceae (); Cynocynaceae (); Asclepiadaceae (); Combretaceae (); Apocynaceae (); Amaranthaceae (); Aroceae (); Cyperaceae (); Anacardiaceae (); Bignoniaceae (); Bombacaceae (); Anarcardiaceae (); Bombacaceae (): Anarcardiaceae (); Caricaceae (); a glyceryl ester of any of the foregoing extracts; a saponin of any of the foregoing extracts; an alkaloid of any of the foregoing extracts; a protein of any of the foregoing extracts; a fat of any of the foregoing extracts; a sugar of any of the foregoing extracts; and any mixture of any of the foregoing.

Composition for treating AIDS and associated conditions

This invention relates to a medicinal aerosol suspension formulation and more particularly, to a medicinal aerosol formulation containing a particulate drug or a combination of at least two particulate drugs, a propellant and a stabilizing agent comprising a water addition.

Water stabilized medicinal aerosol formulation

A method and dispenser for treating a systemic disease in a patient in need of such treatment is disclosed. The method comprising maintaining the inspiratory flow rate and volume of the patient to a certain value and then administering a medicament aerosol formulation to the patient using a breath activated inhalation device.

Method of treating a systemic disease

This invention relates to a combination drug product comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.

Core formulation

A polymeric construct is disclosed. The construct comprises a polysaccharide polymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.

Modulated release particles for lung delivery

A polymeric construct is disclosed. The construct comprises a biodegradable ABA block copolymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.

This invention relates to medicinal aerosol and more formulation and more particularly, to a medicinal aerosol formulation containing rosiglitazone maleate and a fluid carrier.

Medicinal aerosol formulation

The metering valve which includes a material reservoir formed generally above a load bearing bottom hollow, with a toroidal gas chamber formed thereabout. Both the gas chamber and the material reservoir include metering spindles which allow the material to be dispensed and gas to be mixed precisely in a mixing chamber, and dispensed through an orifice.

Powder/liquid metering valve

A medicinal formulation is disclosed comprising pioglitazone or a derivative thereof. The formulation additionally comprises a fluid carrier and a stabilizer.

A method of treating in a human or animal a condition capable of treatment by oral or nasal inhalation has been found. The method comprises administering a medicinal aerosol formulation comprising a selected medicament under conditions where the amount of the selected drug delivered to the site of action, e.g. the lungs, is maximized.

Method of administering a medicinal aerosol formulation

A polymeric construct is disclosed. The construct comprises a polymer selected from silica gel, fumed silica gel, silicic acid, disilicic acid, trisilicic acid, metasilicic acid, and orthosilicic acid in their free or salt forms; silicon dioxide in either of its amporphous, crystalline, or precipitated forms such as Purified Siliceous Earth; diatomacous earth; Fuller's earth, Kieselhurh, Celite; talc; attapulgite; micas; montmorilonite, kaolin, aluminum oxide (Hydrargilite), bentonite, pumice; silanes and siloxanes and any mixture of the foregoing having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.

Modulated release particles for aerosol delivery

A medicinal formulation is disclosed. The formulation comprises (a) a protein or peptide medicament; (b) a fluid carrier for containing said medicament; and a stabilizer selected from an amino acid, a derivative thereof or a mixture of the foregoing.

This invention relates to a medicinal aerosol formulation and more particularly, to a medicinal aerosol formulation containing a troglitazone medicament and a fluid carrier.

Disclosure is made of a method employing real-time imaging techniques such as Magnetic Resonance Imaging in order to investigate the effect of air way structures or administration and respiratory drugs when administered by oral inhalation. The information obtained from the practice of this method yields the criteria that can be used, among other things, to design more efficient aerosol drug delivery systems which optimize the amount of medicine delivered to the lung.

Growing community of inventors

Bridgewater, NJ, United States of America

Akwete Lex Adjei